Equities
TechnologyTechnology Hardware and Equipment
  • Price (USD)187.67
  • Today's Change17.82 / 10.49%
  • Shares traded7.27m
  • 1 Year change+85.28%
  • Beta--
Data delayed at least 15 minutes, as of Feb 09 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Forecasts data is unavailable for this security.

Consensus recommendation

  • 20-Feb-25
  • 20-Nov-25
  • 18-Dec-25
  • 15-Jan-26
  • 05-Feb-26
Select bar for recommendation details.
Recommendations05-Feb-26
Buy5
Outperform12
Hold5
Sell0
Strong Sell0

Share price forecast in USD

The 20 analysts offering 12 month price targets for Astera Labs Inc have a median target of 207.50, with a high estimate of 275.00 and a low estimate of 155.00. The median estimate represents a 22.17% increase from the last price of 169.85.
High61.9%275.00
Med22.2%207.50
Low-8.7%155.00

Earnings history & estimates in USD

On Nov 04, 2025, Astera Labs Inc reported 3rd quarter 2025 earnings of 0.49 per share. This result exceeded the 0.39 consensus of the 16 analysts covering the company and exceeded last year's 3rd quarter results by 0.26.
The next earnings announcement is expected on Feb 10, 2026.
Average growth rate+23.69%
Astera Labs Inc reported annual 2024 earnings of 0.84 per share on Feb 10, 2025.
More ▼

Revenue history & estimates in USD

Astera Labs Inc had 3rd quarter 2025 revenues of 230.58m. This bettered the 206.55m consensus of the 15 analysts covering the company. This was 253.33% above the prior year's 3rd quarter results.
Average growth rate+19.57%
Astera Labs Inc had revenues for the full year 2024 of 396.29m. Last year the company did not report any revenues.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.